Capricor Therapeutics Inc. (CAPR)

NASDAQ

$6.75

$+0.03

(+0.45%)

Regular Market

Capricor Therapeutics Inc. (CAPR) Live Price Chart

Last updated: ⁦2026-10-20 16:27:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Capricor Therapeutics Inc. (CAPR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.75, with a market capitalization of $390.11M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.96 to $40.37. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$390.11M
Open	$6.53
Day's High	$106.80
Day's Low	$0.88
Previous Close	$6.65
Volume	929.87K
Average Volume	7.08M
P/E Ratio	--
52-Week High	$40.37
52-Week Low	$2.96
Dividend Yield	--
Earnings Date	--

Capricor Therapeutics Inc. (CAPR) Stock Price Today

Capricor Therapeutics Inc. (CAPR) is currently trading at $6.75 as of 2026-10-20 16:10:17, up 1.53% ($0.10) from the previous close of $6.65

During today's regular trading session, CAPR has traded between $0.88 and $106.80, with a trading volume of 929.87K shares. The current price is near the lower end of today's range.

Capricor Therapeutics Inc. (CAPR) 7-Day Stock Price Change

Over the past seven days, Capricor Therapeutics Inc. (CAPR) moved from $7.83 to $6.75, representing a decline of 13.77% ($1.08).

The stock traded between $6.47 and $8.05 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.23 million shares, down versus the previous seven-day period, indicating lower trading activity.

CAPR 52-Week Price Position

Position in Range: 10.1%

52W Low$2.96

52W High$40.37

CAPR is currently trading at $6.75, placing it 10.1% of the way from its 52-week low of $2.96 to its 52-week high of $40.37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Capricor Therapeutics Inc. (CAPR)?

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Capricor Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	231
Exchange	NASDAQ
Company Website	https://www.capricor.com

How to Buy Capricor Therapeutics Inc. (CAPR) Stock on MEXC

Eligible investors can buy real shares of Capricor Therapeutics Inc. (CAPR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CAPR and Place Your Order

Open the RealStocks trading page and search for CAPR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Capricor Therapeutics Inc. (CAPR) stock price today?

Capricor Therapeutics Inc. (CAPR) is currently trading at $ 6.75, up 1.53% ($0.10) from the previous close of $ 6.65. Intraday prices update in real time during regular trading hours.

2.Is CAPR stock going up or down today?

As of 2026-10-20 16:10:17, CAPR is trading at $ 6.75, up 1.53% ($0.10) from its previous close of $ 6.65. The stock has traded between $ 0.88 and $ 106.80 during today’s regular session. Past price movements do not guarantee future results.

3.What is CAPR pre-market price?

As of 2026-10-20 16:10:17, CAPR is trading at $ 6.61 in pre-market trading, down 0.60% ($0.04) from the previous close of $ 6.65. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CAPR after-hours price?

As of 2026-10-20 16:10:17, CAPR is trading at $ 6.66 in after-hours trading, up 0.14% ($0.01) from the regular-session close of $ 6.65. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CAPR stock trading now?

CAPR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CAPR sit relative to its 52-week high and low?

Over the past 52 weeks, CAPR has traded between a low of $ 2.96 and a high of $ 40.37. At $ 6.75, the stock is positioned 10.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Capricor Therapeutics Inc. in?

Capricor Therapeutics Inc. (CAPR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Capricor Therapeutics Inc.'s market capitalization and where is it listed?

Capricor Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 390.11M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CAPR valued in terms of P/E ratio and EPS?

CAPR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.23. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Capricor Therapeutics Inc. pay a dividend?

Capricor Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.